🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicentre, open-label, randomised phase II trial comparing azac...
Status
Completed
Location
Barts and the London NHS Trust
Start Date
2012-09
Trial ID
NCT01617226
Treatments Being Tested
This is a multicenter, prospective, single-arm clinical study designed to e...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2026-04-15
Trial ID
NCT07514832
Treatments Being Tested
The purpose of this open label study is to determine whether combining prac...
Status
Completed
Location
Southern Cancer Center
Start Date
2013-12
Trial ID
NCT01993641
Treatments Being Tested
This clinical trial will test the safety and efficacy of combining trametin...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2024-10-11
Trial ID
NCT05849662
Treatments Being Tested
This phase I/II trial studies the side effects, best dose, and effect of ta...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-03-04
Trial ID
NCT05038592
Treatments Being Tested
This is an open-label, Phase 1/2 study in subjects with advanced or metasta...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2017-02-27
Trial ID
NCT02959437
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of navtemadlin w...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2018-02-08
Trial ID
NCT03041688
This phase I trial is to find out the best dose and side effects of tegaviv...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-27
Trial ID
NCT04874480
Treatments Being Tested
This trial tests the safety, side effects, and best dose of navitoclax in c...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2023-01-12
Trial ID
NCT05564650
This phase I trial studies the side effects of genetically modified T cells...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-12-08
Trial ID
NCT03017131